These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 25579350)

  • 1. Pulmonary drug delivery: a role for polymeric nanoparticles?
    d'Angelo I; Conte C; Miro A; Quaglia F; Ungaro F
    Curr Top Med Chem; 2015; 15(4):386-400. PubMed ID: 25579350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dry Powder form of Polymeric Nanoparticles for Pulmonary Drug Delivery.
    Shiehzadeh F; Tafaghodi M
    Curr Pharm Des; 2016; 22(17):2549-60. PubMed ID: 26818872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalable nanoparticulate powders for respiratory delivery.
    Muralidharan P; Malapit M; Mallory E; Hayes D; Mansour HM
    Nanomedicine; 2015 Jul; 11(5):1189-99. PubMed ID: 25659645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
    J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric nanoparticles for pulmonary protein and DNA delivery.
    Menon JU; Ravikumar P; Pise A; Gyawali D; Hsia CC; Nguyen KT
    Acta Biomater; 2014 Jun; 10(6):2643-52. PubMed ID: 24512977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
    Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
    Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled pulmonary drug and gene delivery using polymeric nano-carriers.
    Beck-Broichsitter M; Merkel OM; Kissel T
    J Control Release; 2012 Jul; 161(2):214-24. PubMed ID: 22192571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
    Dilnawaz F
    Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary delivery of inhalable nanoparticles: dry powder inhalers.
    Al-Hallak MH; Sarfraz MK; Azarmi S; Roa WH; Finlay WH; Löbenberg R
    Ther Deliv; 2011 Oct; 2(10):1313-24. PubMed ID: 22826885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations.
    Ngan CL; Asmawi AA
    Drug Deliv Transl Res; 2018 Oct; 8(5):1527-1544. PubMed ID: 29881970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural biodegradable polymers based nano-formulations for drug delivery: A review.
    George A; Shah PA; Shrivastav PS
    Int J Pharm; 2019 Apr; 561():244-264. PubMed ID: 30851391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary delivery of anti-inflammatory agents.
    Ali ME; McConville JT; Lamprecht A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):929-45. PubMed ID: 25534260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of l-Tyrosine-Based Enzyme-Responsive Amphiphilic Poly(ester-urethane) Nanocarriers for Multiple Drug Delivery to Cancer Cells.
    Aluri R; Jayakannan M
    Biomacromolecules; 2017 Jan; 18(1):189-200. PubMed ID: 28064504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
    Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
    Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of nanoscale pulmonary drug delivery formulations by spray drying.
    Bohr A; Ruge CA; Beck-Broichsitter M
    Adv Exp Med Biol; 2014; 811():183-206. PubMed ID: 24683033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-free biodegradable poly(beta-amino ester) nanoparticles for targeted systemic delivery of mRNA to the lungs.
    Kavanagh EW; Tzeng SY; Sharma N; Cutting GR; Green JJ
    Biomaterials; 2025 Feb; 313():122753. PubMed ID: 39217793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle formulations in pulmonary drug delivery.
    Bailey MM; Berkland CJ
    Med Res Rev; 2009 Jan; 29(1):196-212. PubMed ID: 18958847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric nanoparticles for drug delivery to the central nervous system.
    Patel T; Zhou J; Piepmeier JM; Saltzman WM
    Adv Drug Deliv Rev; 2012 May; 64(7):701-5. PubMed ID: 22210134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives.
    Iyer R; Hsia CC; Nguyen KT
    Curr Pharm Des; 2015; 21(36):5233-44. PubMed ID: 26412358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic advantage of inhaled tacrolimus-bound albumin nanoparticles in a bleomycin-induced pulmonary fibrosis mouse model.
    Seo J; Lee C; Hwang HS; Kim B; Thao le Q; Lee ES; Oh KT; Lim JL; Choi HG; Youn YS
    Pulm Pharmacol Ther; 2016 Feb; 36():53-61. PubMed ID: 26768967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.